Risk of cardiovascular, gastrointestinal, and renal adverse events associated with diclofenac immediate and extended release drug products

An observational study using US claims data

Mladsi, D., Goyal, R., Cryer, B., Hopkins, WE., Brater, CD., Korsnes, J., Candrilli, S., Castellsague, J., & Varas-Lorenzo, C. (2015). Risk of cardiovascular, gastrointestinal, and renal adverse events associated with diclofenac immediate and extended release drug products: An observational study using US claims data. Value in Health, 18(3), A292. https://doi.org/10.1016/j.jval.2015.03.1701

Abstract

Safety studies have shown that risks associated with use of non-steroidal anti-inflammatory drugs (NSAIDs) are related to dose and release form; however, there is little US evidence. This study assessed the relationships between diclofenac dose and release form on gastrointestinal (GI), cardiovascular (CV), and renal events using US health care claims.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Far-right and Jihadi terrorism within the United States
Article

Internalizing and externalizing subtypes of alcohol misuse and their relation to drinking motives
Article

Does the relationship between alcohol retail environment and alcohol outcomes vary by depressive symptoms? Findings from a US Survey of Black, Hispanic and White drinkers
Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders